Blog Template

By | 27 Oct, 24 |

@arpbigidisba

Retweet on Twitter arpbigidisba Retweeted

Docusalut @docusalut ·

28 Jul

Nou article a #Docusalut: Pharmacodynamic interaction of apotransferrin and anti-pseudomonal antibiotics against extensively drug-resistant Pseudomonas aeruginosa in a dynamic PK/PD model http://hdl.handle.net/20.500.13003/25036 @microHUSE @aoliverp73 @sonespases @idisbaib #PublicaSalutIB

Reply on Twitter 1949794615193714708 Retweet on Twitter 1949794615193714708 3 Like on Twitter 1949794615193714708 3 X 1949794615193714708

arpbigidisba @arpbigidisba ·

19 Jul

La pasada semana nuestra compañera @EscobarSalom ha participado en el congreso #FEMSmicro2025 que ha tenido lugar en Milán, Italia.

Last week, our labmate @EscobarSalom has participated in #FEMSmicro2025 congress in Milan, Italy.

Reply on Twitter 1946483408185491670 Retweet on Twitter 1946483408185491670 2 Like on Twitter 1946483408185491670 5 X 1946483408185491670

arpbigidisba @arpbigidisba ·

11 Jul

Notícia completa 👇🏻
https://diari.uib.es/Hemeroteca/Un-sistema-pionero-permite-predecir-la-resistencia.cid809294

Reply on Twitter 1943719646395293891 Retweet on Twitter 1943719646395293891 1 Like on Twitter 1943719646395293891 5 X 1943719646395293891

Retweet on Twitter arpbigidisba Retweeted

Docusalut @docusalut ·

10 Jul

Nou article a #Docusalut: 🦠🏥 Analysis of intrahospital and global dissemination and resistome dynamics of NDM-1-producing ST773 high-risk clone http://hdl.handle.net/20.500.13003/24750 @microHUSE @carla_lc2911 @aoliverp73 @idisbaib #PublicaSalutIB

Reply on Twitter 1943339897332363707 Retweet on Twitter 1943339897332363707 4 Like on Twitter 1943339897332363707 4 X 1943339897332363707

Retweet on Twitter arpbigidisba Retweeted

Infosalut @infosalut ·

7 Jul

#PublicaSalutIB @microHUSE i @idisbaib ha participat en la publicació d'un estudi sobre l'ús de la ceftazidima-avibactam indueix multiresistència i limita teràpies col·laterals contra P. aeruginosa https://www.infosalut.com/investigacio/estudis-i-projectes/17616 https://doi.org/10.1038/s41467-025-58597-6

@aoliverp73 @sonespases

Reply on Twitter 1942177351510503830 Retweet on Twitter 1942177351510503830 3 Like on Twitter 1942177351510503830 3 X 1942177351510503830

Retweet on Twitter arpbigidisba Retweeted

Docusalut @docusalut ·

1 Jul

Nou article a #Docusalut: 💊🦠 Ceftazidime-avibactam use selects multidrug-resistance and prevents designing collateral sensitivity-based therapies against Pseudomonas aeruginosa http://hdl.handle.net/20.500.13003/24711 @microHUSE @sonespases @idisbaib #PublicaSalutIB

Reply on Twitter 1940040618232738063 Retweet on Twitter 1940040618232738063 3 Like on Twitter 1940040618232738063 2 X 1940040618232738063

Related

Related

2nd Hands On Workshop on Pseudomonas Aeruginosa Resistance Phenotypes and Whole Genome Sequence Resistome Analysis

Contact